France-Ireland Bilateral Trade Analysis 2023
Complete trade statistics: $18.16B total volume •France deficit: $2.70B
France → Ireland
$7.73B
Exports (2023)
Ireland → France
$10.43B
Imports (2023)
Trade Balance
$2.70B
Deficit for France
Total Trade
$18.16B
Combined Volume
Trade Flow Visualization
Direct trade relationship between France and Ireland. Green line shows exports from France, red line shows imports.
Detailed Product Trade Analysis
Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the France-Ireland commercial relationship and competitive positioning in global markets.
France → Ireland Exports
Export Market Intelligence
🎯 Strategic Export Focus
France's export portfolio to Ireland demonstrates strong diversification across multiple sectors, with heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) representing a key competitive advantage in this bilateral market.
Ireland → France Imports
Import Dependency Profile
📦 Import Strategy Analysis
France's import pattern from Ireland reveals strategic sourcingin medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.
Competitive Trade Position Analysis
Market Leadership
France demonstrates competitive strength in exportingheterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) to Ireland, leveraging comparative advantages.
Trade Complementarity
The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.
Growth Potential
The $18.16B trade volume indicates substantial economic integration with room for expansion in emerging sectors.
Executive Summary: France-Ireland Trade Relationship
Key Trade Highlights 2023
- Total Trade Volume: $18.16 billionrepresenting a significant bilateral economic relationship
- Trade Balance: France maintains a deficit of $2.70 billion
- Export Focus: France's primary exports include heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg, heterocyclic compounds: n.e.c. in headings no. 2933
- Import Dependencies: Key imports from Ireland include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale, telephones for cellular networks or for other wireless networks
Strategic Trade Indicators
📈 Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.
Historical Trade Analysis & Economic Context
Trade Evolution Timeline
2019-2023: Recent Trends
Current trade volume of $18.16B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.
2015-2019: Growth Period
Sustained expansion in bilateral trade driven by complementary economic structures, with France leveraging its comparative advantages in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn).
2010-2015: Foundation Building
Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.
Pre-2010: Early Development
Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.
Key Economic Drivers
Comparative Advantage
France's specialization in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn)complements Ireland's demand patterns, creating natural trade synergies.
Supply Chain Integration
Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.
Market Access & Trade Policy
Favorable trade agreements and market access conditions have facilitated the growth of this $18.16B bilateral relationship.
Trade Pattern Insights
Trade Relationship Outlook
The $18.16B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.
Economic Impact & Strategic Outlook
Economic Impact Assessment
Trade Volume Impact
The $18.16 billion bilateral trade volume represents a significant economic factorfor both economies.
Industrial Integration
Trade flows in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) and medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.
Trade Balance Effects
France's trade deficit of $2.70 billion impacts its overall economic position in this bilateral relationship.
Strategic Future Outlook
🚀Growth Opportunities
⚠️Risk Factors
🎯Strategic Recommendations
- Strengthen cooperation in high-value sectors beyond current trade patterns
- Develop alternative supply chains to reduce dependency risks
- Explore joint ventures in emerging technology sectors
- Enhance trade facilitation and reduce transaction costs
Market Position & Competitive Summary
The bilateral trade relationship between France and Ireland represents a total trade volume of $18.16 billion in 2023. This partnership demonstrates an unfavorable trade balance for France, with imports exceeding exportsby $2.70 billion.
Export Strengths
France's exports to Ireland total $7.73 billion, with competitive advantages in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), representing $2.15B or27.8% of bilateral exports.
Import Dependencies
Imports from Ireland amount to $10.43 billion, highlighting economic interdependence in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale comprising13.4% of total imports.
The trade relationship reflects broader economic patterns and comparative advantages. The trade deficit indicates France's strategic sourcing from Ireland. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.
Download Bilateral Trade Data
Access detailed trade data between France and Ireland in multiple formats.
Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023